发明名称 Compositions and methods for eye whitening
摘要 The invention provides compositions and methods for whitening of eyes. The provided compositions and methods utilize low concentrations of selective α-2 adrenergic receptor agonists. The compositions preferably include brimonidine.
申请公布号 US9259425(B2) 申请公布日期 2016.02.16
申请号 US201314044929 申请日期 2013.10.03
申请人 Eye Therapies LLC 发明人 Horn Gerald
分类号 A61K31/498;A61K9/00;A61K9/08;A61K45/06;A61K31/165;A61K31/198;A61K31/4168;A61K31/4174;A61K31/4178 主分类号 A61K31/498
代理机构 Wood, Phillips, Katz, Clark & Mortimer 代理人 Wood, Phillips, Katz, Clark & Mortimer
主权项 1. A method of increasing whiteness of an eye comprising administering to a subject in need thereof a composition comprising from between about 0.001% to about 0.05% weight by volume of a selective α-2 adrenergic receptor agonist selected from lofexidine, apraclonidine, mivazerol, clonidine, brimonidine, alpha methyl dopa, guanfacine, dexmedetomidine, (+)-(S)-4-[1-(2,3-dimethyl-phenyl)-ethyl]-1,3-dihydro-imidazole-2-thione, and 1-[(imidazolidin-2-yl)imino]indazole, or a pharmaceutically acceptable salt thereof.
地址 Dana Point CA US